CN Patent

CN1246847A — 作为Xa因子抑制剂的含氮杂芳族化合物

Assigned to Bristol Myers Squibb Pharma Co · Expires 2000-03-08 · 26y expired

What this patent protects

本申请描述用作Xa因子抑制剂的式(Ⅰ)含氮杂芳族化合物和其衍生物或其药学上可接受的盐或前体药物,在式(Ⅰ)中J为N或NH,D可以为C(=NH)NH 2 。

USPTO Abstract

本申请描述用作Xa因子抑制剂的式(Ⅰ)含氮杂芳族化合物和其衍生物或其药学上可接受的盐或前体药物,在式(Ⅰ)中J为N或NH,D可以为C(=NH)NH 2 。

Drugs covered by this patent

Patent Metadata

Patent number: CN1246847A
Jurisdiction: CN
Classification: —
Expires: 2000-03-08
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Pharma Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.